Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 18, Number 1—January 2012

Research

Modeling Insights into Haemophilus influenzae Type b Disease, Transmission, and Vaccine Programs

Michael L. Jackson1Comments to Author , Charles E. Rose, Amanda Cohn, Fatima Coronado, Thomas A. Clark, Jay D. Wenger, Lisa Bulkow, Michael G. Bruce, Nancy E. Messonnier, and Thomas W. Hennessy
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 3

Figure 3. Predicted effects of extended Haemophilus influenzae type b (Hib) vaccine shortage on the incidence of invasive Hib disease in the United States (A) and of switching from PRP-OMP to PRP-T vaccine in the Alaska Native population (B). See text for complete description of shortage scenarios. PRP-OMP, Hib polyribosylribitol phosphate polysaccharide conjugated to Neisseria meningitidis outer membrane protein; PRP-T, polyribosylribitol phosphate polysaccharide conjugated to tetanus toxoid.

Main Article

1Current affiliation: Group Health Research Institute, Seattle, Washington, USA.

TOP